Abstract

Oncology services utilize about 15% of the blood transfusion resources in the USA. Red blood cell transfusion is performed immediately before, during or after major surgery to compensate for blood loss and hemodilution. However, a lack of evidence-based guidelines leads to variable transfusion practices among clinicians. The benefits of transfusing blood products are obvious in life-threatening low blood cell counts or bleeding, but it is becoming apparent that deliberate blood transfusion in some cancer patients can trigger negative clinical impacts. This review attempts to provide an overview of the impact of red blood cell transfusion in patients suffering from various types of oncologic pathologies.

Original languageEnglish
Pages (from-to)287-290
Number of pages4
JournalTransfusion and Apheresis Science
Volume56
Issue number3
DOIs
Publication statusPublished - Jun 1 2017

    Fingerprint

Keywords

  • Cancer
  • Prognosis
  • Recurrence
  • Red blood cells
  • Transfusion

ASJC Scopus subject areas

  • Hematology

Cite this

Iqbal, N., Haider, K., Sundaram, V., Radosevic, J., Burnouf, T., Seghatchian, J., & Goubran, H. (2017). Red blood cell transfusion and outcome in cancer. Transfusion and Apheresis Science, 56(3), 287-290. https://doi.org/10.1016/j.transci.2017.05.014